Opportunity Information: Apply for RFA DA 12 008
Apply for RFA DA 12 008
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Integration of Drug Abuse Prevention and Treatment in Primary Care Settings (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on May 20, 2011 and posted on May 20, 2011.
- Applicants must submit their applications by Oct 31, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Independent school districts County governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Small businesses State governments City or township governments Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non U.S.) components of U.S. Organizations are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Integration of Drug Abuse Prevention and Treatment in Primary Care Settings (R01) funding opportunity (RFA-DA-12-008) is a National Institutes of Health initiative from the National Institute on Drug Abuse (NIDA) focused on strengthening how routine medical care addresses substance use. The core idea is that outcomes related to drug abuse and addiction can improve when proven prevention, screening, and treatment approaches are built directly into the places where most people already seek healthcare. Rather than treating substance use services as separate or specialty-only, this opportunity emphasizes making them a practical, functioning part of everyday primary care, with the goal of improving prevention, early detection, timely intervention, and overall management of substance use disorders and related consequences.
This R01 specifically calls for translation and implementation research, meaning the work should go beyond showing that an intervention can work under ideal conditions and instead test how evidence-based approaches can be adopted, delivered, and sustained in real-world clinical environments. NIDA is looking for hypothesis-driven studies that compare or evaluate strategies and service delivery models for integrating substance abuse prevention interventions and/or treatment services within primary care. Applicants are expected to identify clear, testable research questions and outcomes that can demonstrate what integration methods are most effective, feasible, scalable, and appropriate for routine practice.
Primary care is interpreted broadly in this announcement. Proposed studies can be situated in public or private sector healthcare settings where patients receive general medical services, including office-based practices and clinics, family practice, pediatric and adolescent medicine, obstetrics, general practice settings, and emergency departments. This range signals an interest in integration across the full lifespan and across common points of contact with the healthcare system, including settings where substance use risks may be identified incidentally or where brief intervention and referral pathways could be particularly impactful.
From a funding and administrative standpoint, this is a discretionary grant opportunity using the NIH R01 mechanism. The estimated total program funding listed is $4,000,000, with an award ceiling of $500,000. The posting and creation date is May 20, 2011, with an original and current closing date of October 31, 2011, and an archive date of December 1, 2011. The opportunity is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement indicated.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township, special district governments, independent school districts, and certain public housing authorities/Indian housing authorities. A wide range of nonprofit and educational entities are eligible, including 501(c)(3) nonprofits (other than institutions of higher education), nonprofits without 501(c)(3) status (other than institutions of higher education), public and state-controlled institutions of higher education, and private institutions of higher education. For-profit organizations (including small businesses and other for-profits) may apply, and the announcement also explicitly includes faith-based and community-based organizations and multiple institution types such as Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and regional organizations. U.S. territories or possessions are included, and certain federal agencies are also identified as eligible. At the same time, non-U.S. entities (foreign organizations) are not eligible to apply, and foreign components of U.S. organizations are not allowed, keeping the work fully domestic in scope.
Overall, the grant is aimed at building practical, evidence-informed pathways that help primary care settings routinely identify substance use risk, deliver prevention or early intervention, and connect patients to effective treatment when needed. The emphasis on implementation strategies and service delivery models reflects the main question NIDA is trying to answer through this program: what approaches actually make integration work in real clinics, with real patients, under real operational constraints, and how can those approaches be replicated and sustained across diverse primary care environments. For full details, applicants were directed to the official NIH funding announcement page at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-12-008.html, with NIH Office of Extramural Research support contacts provided for access or linking issues.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled "Integration of Drug Abuse Prevention and Treatment in Primary Care Settings (R01)" and is identified as RFA-DA-12-008.
Which agency is offering this grant?
This is a National Institutes of Health (NIH) initiative led by the National Institute on Drug Abuse (NIDA).
What is the main purpose of the grant?
The goal is to strengthen how routine medical care addresses substance use by integrating evidence-based prevention, screening, and treatment approaches directly into primary care settings. The intent is to improve prevention, early detection, timely intervention, and ongoing management of substance use disorders and related consequences in the places where most people already receive healthcare.
What type of research is being requested?
The announcement calls for translation and implementation research. This means studies should focus on how evidence-based approaches can be adopted, delivered, and sustained in real-world clinical environments, rather than only demonstrating that an intervention works under ideal conditions.
What kinds of studies does NIDA want to fund under this R01?
NIDA is looking for hypothesis-driven studies that compare or evaluate strategies and service delivery models for integrating substance abuse prevention interventions and/or treatment services within primary care. Applications are expected to include clear, testable research questions and measurable outcomes.
Does the opportunity focus on prevention, treatment, or both?
Both. The opportunity emphasizes integrating substance abuse prevention interventions and/or treatment services into routine primary care.
What does "integration" mean in this announcement?
Integration is framed as making substance use prevention, screening, and treatment a practical and functioning part of everyday primary care, rather than treating substance use services as separate or specialty-only. The emphasis is on approaches that work under typical clinic constraints and can be sustained over time.
How is "primary care" defined for this funding opportunity?
Primary care is interpreted broadly. Eligible settings include public or private sector healthcare environments where patients receive general medical services, such as office-based practices and clinics, family practice, pediatric and adolescent medicine, obstetrics, general practice settings, and emergency departments.
Can emergency departments be used as the primary care setting for a study?
Yes. Emergency departments are explicitly included among the settings where studies may be situated.
Is the opportunity intended to apply across different age groups?
Yes. The inclusion of pediatric and adolescent medicine as well as obstetrics and general practice settings signals interest in integration across the full lifespan and at common points of contact with the healthcare system.
What outcomes is NIDA trying to improve through this program?
The program is oriented toward improving outcomes related to drug abuse and addiction by strengthening prevention, early detection, timely intervention, and overall management of substance use disorders and related consequences within routine healthcare.
What specific themes does the program emphasize when evaluating integration approaches?
The announcement emphasizes identifying integration methods that are effective, feasible, scalable, and appropriate for routine practice, with a focus on real-world implementation and sustainability.
What grant mechanism is used?
This opportunity uses the NIH R01 mechanism and is described as a discretionary grant opportunity.
How much total funding is estimated for the program?
The estimated total program funding listed is $4,000,000.
Is there an award ceiling?
Yes. The award ceiling listed is $500,000.
Is cost sharing or matching required?
No. The opportunity indicates that there is no cost sharing or matching requirement.
What is the CFDA number for this opportunity?
The opportunity is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
When was this opportunity posted?
The posting and creation date is May 20, 2011.
What was the application closing date?
The original and current closing date listed is October 31, 2011.
Has this opportunity been archived?
Yes. The archive date listed is December 1, 2011.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; and certain public housing authorities/Indian housing authorities. Eligible organizations also include a wide range of nonprofits and educational entities (including public/state-controlled and private institutions of higher education), and for-profit organizations (including small businesses and other for-profits). The announcement also explicitly includes faith-based and community-based organizations and multiple institution types such as Hispanic-serving institutions, HBCUs, TCCUs, Alaska Native and Native Hawaiian Serving Institutions, and regional organizations. U.S. territories or possessions are included, and certain federal agencies are also identified as eligible.
Are foreign organizations eligible to apply?
No. Non-U.S. entities (foreign organizations) are not eligible to apply.
Are foreign components of U.S. organizations allowed?
No. Foreign components of U.S. organizations are not allowed, meaning the work is intended to be fully domestic in scope.
Does the announcement limit applicants to nonprofits?
No. The eligibility language explicitly includes nonprofit entities, educational institutions, governmental entities, and for-profit organizations (including small businesses).
Where can applicants find the official announcement and details?
Applicants were directed to the official NIH funding announcement page: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-12-008.html
Is there a support contact for access or linking issues to the NIH page?
Yes. The opportunity notes that NIH Office of Extramural Research support contacts were provided for access or linking issues.
What is the big question NIDA is trying to answer with this program?
The program is designed to determine what approaches actually make integration work in real clinics, with real patients, under real operational constraints, and how those approaches can be replicated and sustained across diverse primary care environments.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Systems for Improved Access to Pharmaceuticals and Services
Previous opportunity: Surveying Sensitive Plant Species Grahams White River Penstemon.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 12 008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 12 008) also looked into and applied for these:
| Funding Opportunity |
|---|
| Remote Monitoring System for Detecting Cocaine Ingestion/Intoxication (R01) Apply for RFA DA 12 007 Funding Number: RFA DA 12 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Community Clinical Oncology Program Groups (U10) Apply for RFA CA 11 006 Funding Number: RFA CA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Research Bases (U10) Apply for RFA CA 11 007 Funding Number: RFA CA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program Groups (U10) Apply for RFA CA 11 008 Funding Number: RFA CA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Phase Clinical Trials in Imaging and Image Guided Interventions (R21) Apply for PAR 11 216 Funding Number: PAR 11 216 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Cancer Target Discovery and Development (CTDD) Network (U01) Apply for RFA CA 11 010 Funding Number: RFA CA 11 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R01) Apply for RFA MH 12 060 Funding Number: RFA MH 12 060 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R34) Apply for RFA MH 12 061 Funding Number: RFA MH 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| High End Instrumentation Grant Program (S10) Apply for PAR 11 228 Funding Number: PAR 11 228 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research IDeA CTRU54 Apply for PAR 11 229 Funding Number: PAR 11 229 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Epidemiology of Drug Abuse (R01) Apply for PA 11 230 Funding Number: PA 11 230 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epidemiology of Drug Abuse (R21) Apply for PA 11 231 Funding Number: PA 11 231 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epidemiology of Drug Abuse (R03) Apply for PA 11 232 Funding Number: PA 11 232 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Probes for Microimaging The Nervous System (SBIR R43/R44) Apply for PA 09 062 Funding Number: PA 09 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 12 008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.